FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
7,911 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Pegasyspeginterferon alfa-2a | Peginterferon alfa-2a 180 ug/.5mL | Injection, SolutionSubcutaneous | pharmaand GmbH | BLA | 82154-0451 | 82154-0451-04 | — |
| PEGO Acne Buster Salicylic Acid Drying Serumzinc oxide,niacinamide,colloidal sulfur,azelaic acid,salicylic acid. | Zinc oxide .2 mg/10mL + 4 more ingredients | LiquidTopical | Guangzhou Senmai Biotechnology Co.,Ltd. | OTC monograph drug | 84509-108 | 84509-0108-01 | — |
| Pellixcalcipotriene | Calcipotriene .05 mg/mL | SolutionTopical | Perfero Pharma, Inc. | ANDA | 87143-300 | 87143-0300-60 |
| — |
| Pelotan Sunscreen Broad Spectrum SPF 30avobenzone, octinoxate, octocrylene | Octinoxate 75 mg/mL + 2 more ingredients | SprayTopical | Pelotan LLC | OTC monograph drug | 85962-001 | 85962-0001-0185962-0001-02 | — |
|---|
| Pelotan Sunscreen Broad Spectrum SPF 30avobenzone, octinoxate, octocrylene | Octocrylene 100 mg/mL + 2 more ingredients | StickTopical | Pelotan LLC | OTC monograph drug | 85962-002 | 85962-0002-01 | — |
|---|
| Pemazyrepemigatinib | Pemigatinib 4.5 mg/1 | TabletOral | Incyte Corporation | NDA | 50881-026 | 50881-0026-01 | — |
|---|
| Pemazyrepemigatinib | Pemigatinib 9 mg/1 | TabletOral | Incyte Corporation | NDA | 50881-027 | 50881-0027-01 | — |
|---|
| Pemazyrepemigatinib | Pemigatinib 13.5 mg/1 | TabletOral | Incyte Corporation | NDA | 50881-028 | 50881-0028-01 | — |
|---|
| Pemetrexed | Pemetrexed disodium 1 g/40mL | Injection, Solution, ConcentrateIntravenous | Hospira, Inc. | NDA | 0409-0004 | 00409-0004-04 | — |
|---|
| Pemetrexed | Pemetrexed disodium 100 mg/4mL | Injection, Solution, ConcentrateIntravenous | Hospira, Inc. | NDA | 0409-0020 | 00409-0020-02 | — |
|---|
| Pemetrexed | Pemetrexed disodium 500 mg/20mL | Injection, Solution, ConcentrateIntravenous | Hospira, Inc. | NDA | 0409-0021 | 00409-0021-03 | — |
|---|
| Pemetrexed | Pemetrexed disodium 100 mg/4mL | Injection, Solution, ConcentrateIntravenous | Hospira, Inc. | NDA | 0409-1045 | 00409-1045-01 | — |
|---|
| Pemetrexed | Pemetrexed disodium 500 mg/20mL | Injection, Solution, ConcentrateIntravenous | Hospira, Inc. | NDA | 0409-2188 | 00409-2188-01 | — |
|---|
| Pemetrexed | Pemetrexed disodium 1 g/40mL | Injection, Solution, ConcentrateIntravenous | Hospira, Inc. | NDA | 0409-3532 | 00409-3532-01 | — |
|---|
| Pemetrexed | Pemetrexed monohydrate 25 mg/mL | Solution, ConcentrateIntravenous | Teva Pharmaceuticals, Inc. | NDA | 0480-4514 | 00480-4514-01 | — |
|---|
| Pemetrexed | Pemetrexed monohydrate 25 mg/mL | Solution, ConcentrateIntravenous | Teva Pharmaceuticals, Inc. | NDA | 0480-4515 | 00480-4515-01 | — |
|---|
| Pemetrexed | Pemetrexed monohydrate 25 mg/mL | Solution, ConcentrateIntravenous | Teva Pharmaceuticals, Inc. | NDA | 0480-4516 | 00480-4516-01 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 100 mg/4mL | Injection, SolutionIntravenous | Sandoz Inc. | NDA | 0781-3518 | 00781-3518-76 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 500 mg/20mL | Injection, SolutionIntravenous | Sandoz Inc. | NDA | 0781-3519 | 00781-3519-90 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 1000 mg/40mL | Injection, SolutionIntravenous | Sandoz Inc. | NDA | 0781-3520 | — | — |
|---|
| Pemetrexed | Pemetrexed disodium hemipentahydrate 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | Accord Healthcare Inc. | ANDA | 16729-229 | 16729-0229-03 | — |
|---|
| Pemetrexed | Pemetrexed disodium hemipentahydrate 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Accord Healthcare Inc. | ANDA | 16729-230 | 16729-0230-11 | — |
|---|
| Pemetrexed | Pemetrexed disodium hemipentahydrate 1 g/40mL | Injection, Powder, Lyophilized, For solutionIntravenous | Accord Healthcare Inc. | ANDA | 16729-244 | 16729-0244-38 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 100 mg/4.2mL | Injection, Powder, Lyophilized, For solutionIntravenous | Sagent Pharmaceuticals | ANDA | 25021-260 | 25021-0260-10 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Sagent Pharmaceuticals | ANDA | 25021-261 | 25021-0261-50 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | Camber Pharmaceuticals, Inc. | ANDA | 31722-336 | 31722-0336-31 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Camber Pharmaceuticals, Inc. | ANDA | 31722-337 | 31722-0337-31 | — |
|---|
| Pemetrexed | Pemetrexed disodium hemipentahydrate 100 mg/1 | Injection, Powder, For solutionIntravenous | Solco Healthcare US, LLC | ANDA | 43547-632 | 43547-0632-01 | — |
|---|
| Pemetrexed | Pemetrexed disodium hemipentahydrate 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | Eugia US LLC | ANDA | 55150-381 | 55150-0381-01 | — |
|---|
| Pemetrexed | Pemetrexed disodium hemipentahydrate 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Eugia US LLC | ANDA | 55150-382 | 55150-0382-01 | — |
|---|
| Pemetrexed | Pemetrexed disodium hemipentahydrate 1000 mg/40mL | Injection, Powder, Lyophilized, For solutionIntravenous | Eugia US LLC | ANDA | 55150-383 | 55150-0383-01 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | Fresenius Kabi USA, LLC | ANDA | 63323-134 | 63323-0134-10 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Fresenius Kabi USA, LLC | ANDA | 63323-450 | 63323-0450-50 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 750 mg/30mL | Injection, Powder, Lyophilized, For solutionIntravenous | Fresenius Kabi USA, LLC | ANDA | 63323-621 | 63323-0621-00 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 1 g/40mL | Injection, Powder, Lyophilized, For solutionIntravenous | Fresenius Kabi USA, LLC | ANDA | 63323-622 | 63323-0622-00 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 100 mg/10mL | InjectionIntravenous | Shilpa Medicare Limited | NDA | 63759-3048 | 63759-3048-01 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 500 mg/50mL | InjectionIntravenous | Shilpa Medicare Limited | NDA | 63759-3049 | 63759-3049-01 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 1000 mg/100mL | InjectionIntravenous | Shilpa Medicare Limited | NDA | 63759-3050 | 63759-3050-01 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | Qilu Pharmaceutical Co., Ltd. | ANDA | 67184-0503 | 67184-0503-01 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Qilu Pharmaceutical Co., Ltd. | ANDA | 67184-0504 | 67184-0504-01 | — |
|---|
| Pemetrexed | Pemetrexed disodium hemipentahydrate 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | BluePoint Laboratories | ANDA | 68001-535 | 68001-0535-41 | — |
|---|
| Pemetrexed | Pemetrexed disodium hemipentahydrate 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | BluePoint Laboratories | ANDA | 68001-536 | 68001-0536-41 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | BluePoint Laboratories | ANDA | 68001-538 | 68001-0538-41 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | BluePoint Laboratories | ANDA | 68001-539 | 68001-0539-41 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | BluePoint Laboratories | ANDA | 68001-543 | 68001-0543-41 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | BluePoint Laboratories | ANDA | 68001-544 | 68001-0544-41 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 750 mg/30mL | Injection, Powder, Lyophilized, For solutionIntravenous | BluePoint Laboratories | ANDA | 68001-545 | 68001-0545-41 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 1000 mg/40mL | Injection, Powder, Lyophilized, For solutionIntravenous | BluePoint Laboratories | ANDA | 68001-546 | 68001-0546-41 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium heptahydrate 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | Somerset Therapeutics LLC | ANDA | 70069-834 | 70069-0834-01 | — |
|---|
| Pemetrexedpemetrexed disodium | Pemetrexed disodium heptahydrate 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Somerset Therapeutics LLC | ANDA | 70069-835 | 70069-0835-01 | — |
|---|